CSIMarket
 
Fsd Pharma Inc   (NASDAQ: HUGE)
Other Ticker:  
 
 
Price: $0.0899 $-0.01 -10.100%
Day's High: $0.1042 Week Perf: -0.77 %
Day's Low: $ 0.09 30 Day Perf: -39.26 %
Volume (M): 22,326 52 Wk High: $ 1.09
Volume (M$): $ 2,007 52 Wk Avg: $0.42
Open: $0.09 52 Wk Low: $0.07



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) -
 Employees 19
 Revenues (TTM) (Millions $) 5
 Net Income (TTM) (Millions $) -18
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 1

Fsd Pharma Inc
FSD Pharma Inc is a Canadian-based pharmaceutical research and development company. It focuses on the development of cannabinoid-based treatments for various medical conditions. The company is dedicated to discovering and commercializing innovative therapies that can potentially improve the lives of patients. FSD Pharma also owns a fully licensed facility for the cultivation and production of organic cannabis. Its mission is to become a global leader in the development of cannabinoid-based medicines.


   Company Address: 199 Bay St. Toronto 0 ON
   Company Phone Number: 854-8884   Stock Exchange / Ticker: NASDAQ HUGE


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CLVR     
CVSI   -1.62%    
INCR   -5.71%    
INM        2.24% 
LIFD        2.24% 
NEPT   -54.54%    
• View Complete Report
   



Fsd Pharma Inc

Fsd Pharma Inc Posts Strong Revenue Growth in Latest Financial Report

Fsd Pharma Inc, a pharmaceutical company, has released its financial results for the period ending December 31, 2023. The company reported a revenue of $4.56 million during this period, indicating growth in its financial performance. Additionally, Fsd Pharma Inc was able to reduce its net shortfall from $-23.607 million in the previous year to $-17.902 million, signifying a positive trend for the company.
In the fiscal 12 months of 2023, Fsd Pharma Inc experienced a shortfall of $-17.90 million and generated a revenue of $4.56 million. In comparison to the previous fiscal year, where the company reported a break-even of $0.08 per share, there was no growth as the company maintained a break-even status. This indicates stability in its financials over the mentioned period.










Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com